CIVICASCRIPT Trademark

Trademark Overview

On Tuesday, January 26, 2021, a trademark application was filed for CIVICASCRIPT with the United States Patent and Trademark Office. The USPTO has given the CIVICASCRIPT trademark a serial number of 90489341. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by CIVICA, INC.. The CIVICASCRIPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
civicascript

General Information

Serial Number90489341
Word MarkCIVICASCRIPT
Filing DateTuesday, January 26, 2021
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7081273
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 27, 2021
Primary Code005
First Use Anywhere DateWednesday, August 3, 2022
First Use In Commerce DateWednesday, August 3, 2022

Trademark Owner History

Party NameCIVICA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLehi, UT 84043
Party NameCIVICA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLehi, UT 84043
Party NameCIVICA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLehi, UT 84043

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, May 6, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 5, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 4, 2022NON-FINAL ACTION E-MAILED
Friday, November 4, 2022SU - NON-FINAL ACTION - WRITTEN
Sunday, October 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 21, 2022USE AMENDMENT FILED
Sunday, October 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 21, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 1, 2022SOU EXTENSION 1 GRANTED
Friday, April 1, 2022SOU EXTENSION 1 FILED
Friday, April 1, 2022TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 12, 2021ASSIGNED TO EXAMINER
Tuesday, April 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 29, 2021NEW APPLICATION ENTERED

Related Keywords

civicascript cancer treatment products pharmaceutical